Form 4/A for URGN UroGen Pharma Ltd.

Accepted 2024-02-05 00:00:00 ET · period of report 2024-01-31 · accession 0001437749-24-003153 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MA	2024-02-05	2024-02-01	URGN	Schoenberg Mark	Chief Medical Off	S - Sale	$15.78	-3,789	150.0K	-2%	-$59.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares	2024-02-01	S	D	1,137	$15.78	149,423	D	—	—	(F1) This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. (F2) This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.
2	Common	Ordinary Shares	2024-02-01	S	D	1,894	$15.78	151,437	D	—	—	(F1) This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. (F2) This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.
3	Common	Ordinary Shares	2024-02-01	S	D	758	$15.78	149,998	D	—	—	(F1) This amendment corrects and restates the date of sale reported in the original Form 4 filed on February 2, 2024. (F2) This amendment corrects and restates the sales price reported in the original Form 4 filed on February 2, 2024.